A synthetic tetrapeptide in the Khavinson short-peptide family (commonly reported as Ala-Glu-Asp-Leu or Ala-Glu-Asp-Lys depending on source), associated with cartilage tissue. Reported in Russian preclinical studies to modulate chondrocyte metabolism and joint-tissue regeneration. Part of the Cytogen class.
For research purposes only. Not medical advice.
Modern Research Peptides currently lists Cartalax at $3.00/mg, the lowest indexed price across 8 tracked research peptide vendors.
Cartalax ranges from $2.40/mg to $3.95/mg across 9 listings from 8 research peptide vendors, normalized to USD per milligram and refreshed daily.
8 research peptide vendors currently list Cartalax on PeptideScouter, with 6 in stock right now. We track 9 active listings across size and kit variants.